Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma

Published:2016-09 Issue:9 Volume:27 Page:1782-1787
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Simonelli M.,Zucali P.,Santoro A.,Thomas M.B.,de Braud F.G.,Borghaei H.,Berlin J.,Denlinger C.S.,Noberasco C.,Rimassa L.,Kim T.-Y.,English P.A.,Abbattista A.,Gallo Stampino C.,Carpentieri M.,Williams J.A.

Funder

Pfizer Inc.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/9/1782/16698266/mdw240.pdf

Reference23 articles.

1. Hepatocellular carcinoma: systemic therapies and future perspectives;Mikhail;Expert Rev Anticancer Ther,2014

2. Hepatocellular carcinoma: reasons for Phase III failure and novel perspectives on trial design;Llovet;Clin Cancer Res,2014

3. TGF-β signal transduction;Massague;Annu Rev Biochem,1998

4. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling;Seki;Circ Res,2003

5. Mechanisms of TGF-beta signaling from cell membrane to the nucleus;Shi;Cell,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential;Biomolecules;2024-08-15

2. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer;International Journal of Molecular Sciences;2024-06-05

3. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

4. Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study;PLOS ONE;2023-11-09

5. Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study;BMC Medicine;2023-10-20